Anti-Band III [Q1/156]
Invented by Dr Jacqueline Cordell from University of Oxford
Invented at University of Oxford
- Datasheet
- References (0)
- Inventor Info
Info
| Catalogue Number | 151337 |
| Applications | IHC IF IP WB |
| Antigen/Gene or Protein Targets | Band III |
| Reactivity | Human |
| Relevance | Band III is a protein associated with the surface membrane of red blood cells and their precursors. It is the major glycoprotein of the erythrocyte membrane and mediates exchange of chloride and bicarbonate across the phospholipid bilayer and plays a central role in respiration of carbon dioxide. Band III is also a potential binding site for haemoglobin. |
| Host | Mouse |
| Immunogen | Foetal liver cells |
| Subclass | IgG1 kappa |
| Myeloma Used | P3/NS1/1-Ag4.1 |
| Recommended Growing Conditions | RPMI 1640 + 10% FCS + penicillin (100U/ml) + streptomycin (100mg/l) + glutamine (2mM) + HAT |
| Notes | Ultroser G can be used at 1% if the cells are not growing well. |
| Research Area | Cardiovascular |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
